TRU-SENTIMENT · DeltaNeutral
NBIX Trading Analysis - 09/18/2026 10:39 AM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
NBIX (Neurocrine Biosciences Inc) at $149.75. True Sentiment Balanced, delta 40-60 call 0% / put 0%, call $0 vs put $0. RSI 40.4.
- Symbol
- NBIX
- Price
- $149.75
- Article bias (separate from True Sentiment)
- bearish
- Conviction
- medium
- Published
- 2026-09-18 10:39:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Overall options flow sentiment: Balanced
Call vs Put dollar volume: No clear directional conviction.
The pure directional positioning suggests a neutral near-term expectation.
Key Statistics: NBIX
Fundamental Snapshot
Valuation
| P/E (Trailing) | 22.26 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 12.77 |
Profitability
| EPS (Trailing) | $6.82 |
| EPS (Forward) | N/A |
| ROE | 19.10% |
| Net Margin | 20.91% |
Financial Health
| Revenue (TTM) | $3.37B |
| Debt/Equity | 0.45 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for NBIX include:
- Neurocrine Biosciences Announces Second Quarter 2026 Financial Results and Provides Corporate Update
- Neurocrine Biosciences' Ingrezza Continues to Show Promise in Treating Tardive Dyskinesia
- Neurocrine Biosciences to Present at Upcoming Healthcare Conference
These headlines suggest that NBIX has been experiencing significant developments in their financials and product pipeline, which could impact the stock's performance.
Fundamental Analysis:
Based on the provided fundamentals data:
- Revenue: $3,373,900,000
- Trailing EPS: $6.82
- Trailing P/E: 22.26
- Debt/Equity: 0.45
- ROE: 19.10%
The company's revenue and EPS indicate a stable financial position. The P/E ratio suggests that the stock may be fairly valued. The debt/equity ratio and ROE indicate a relatively healthy balance sheet and profitability.
Current Market Position:
Current price: $149.75
Recent price action: The stock has been trading in a range with a slight downward trend.
Key support and resistance levels: $149.26 (Bollinger Band lower bound) and $159.69 (Bollinger Band upper bound)
Technical Analysis:
SMA trends:
- 5-day SMA: $151.67
- 20-day SMA: $154.48
- 50-day SMA: $162.31
The stock is currently below its 5-day, 20-day, and 50-day SMAs, indicating a downward trend.
RSI (14): 40.43, which suggests a neutral momentum.
MACD: -2.53, which indicates a bearish signal.
Bollinger Bands: The stock is currently near the lower bound of the Bollinger Bands, which could indicate a potential bounce.
True Sentiment Analysis (Delta 40-60 Options):
Overall options flow sentiment: Balanced
Call vs Put dollar volume: No clear directional conviction.
The pure directional positioning suggests a neutral near-term expectation.
Key Price Levels:
Support: $149.26 (Bollinger Band lower bound)
Resistance: $159.69 (Bollinger Band upper bound)
Entry: $149.75
25-Day Price Forecast:
NBIX is projected for $147.50 to $152.00
Based on current SMA trends, RSI momentum, MACD signals, and recent volatility (ATR), the stock price may fluctuate within this range.
Defined Risk Strategy Recommendations:
Based on the price forecast:
- Bull Call Spread: Buy 150C and Sell 155C
- Bear Put Spread: Buy 145P and Sell 140P
- Iron Condor: Buy 145P, Sell 140P, Buy 155C, Sell 160C
These strategies align with the projected price range and offer defined risk.
Risk Factors:
Technical warning signs:
- Downward trend
Sentiment divergences:
- None
Volatility and ATR considerations:
- ATR: 4.19
Summary & Conviction Level:
Overall bias: Bearish
Conviction level: Medium
One-line trade idea: Consider a defined risk strategy given the neutral sentiment and technical indicators.
View NBIX Options Chain